Venditto Laura, Morano Sonia, Ferrante Giuliana, Piazza Michele, Tenero Laura, Piacentini Giorgio, Pecoraro Luca
Pediatric Clinic, Department of Surgical Sciences, Dentistry, Gynecology and Pediatrics, University of Verona, 37126 Verona, Italy.
Children (Basel). 2024 Feb 18;11(2):262. doi: 10.3390/children11020262.
Asthma is a disease that has been described since the times of Hammurabi. However, it is only since the 1960s that effective therapeutic strategies have been available. Pathogenic mechanisms underlying the disease have been deeply studied, contributing to creating a "patient-specific asthma" definition. Biological drugs have been approved over the last twenty years, improving disease management in patients with severe asthma via a "precision medicine-driven approach". This article aims to describe the evolution of scientific knowledge in childhood asthma, focusing on the most recent biological therapies and their indications for patients with severe asthma.
哮喘是一种自汉谟拉比时代就已被描述的疾病。然而,直到20世纪60年代才出现有效的治疗策略。该疾病的致病机制已得到深入研究,有助于形成“患者特异性哮喘”的定义。在过去二十年中,生物药物已获批准,通过“精准医学驱动的方法”改善了重度哮喘患者的疾病管理。本文旨在描述儿童哮喘科学知识的演变,重点关注最新的生物疗法及其在重度哮喘患者中的应用指征。